Cronos Group Inc.

CRON Biotech & pharma

Sells cannabis products to medical and adult-use markets.

Jun 2026Revenue $179M/yrExpenses $182M/yr
Expected break-even Jul 2026
Figures by year

When will Cronos Group be profitable?

Its revenue and expense trends are projected to cross in Jul 2026. In the 12 months to Jun 2026, revenue was $179M and expenses $182M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$147M$164M−$17.4M
Dec 2024$118M$194M−$76.5M
Dec 2023$87.2M$172M−$84.8M
Dec 2022$86.7M$198M−$111M
Dec 2021$64.6M$357M−$292M
Dec 2020$46.7M$266M−$219M
Dec 2019$23.8M$177M−$153M
Dec 2018$12.1M$32.6M−$20.4M
Dec 2017$3.15M$9.27M−$6.12M